Y. Matsuyama

发表

Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials

T. Yamaguchi, Y. Ohashi, Y. Matsuyama, 2002, Statistical methods in medical research.

A Bayesian hierarchical survival model for the institutional effects in a multi-centre cancer clinical trial.

Y. Ohashi, Y. Matsuyama, J. Sakamoto, 1998, Statistics in medicine.

Model selection criterion for causal parameters in structural mean models based on a quasi‐likelihood

Y. Ohashi, Y. Matsuyama, M. Taguri, 2014, Biometrics.

Comparative validity of methods to select appropriate cutoff weight for probabilistic linkage without unique personal identifiers

Yasuo Ohashi, Jessica M Franklin, Soko Setoguchi, 2016, Pharmacoepidemiology and drug safety.

Estimation of treatment effect adjusting for treatment changes using the intensity score method: Application to a large primary prevention study for coronary events (MEGA study)

Y. Ohashi, Y. Matsuyama, Yukari Tanaka, 2008, Statistics in medicine.

Marginal Structural Models as a Tool for Standardization

Y. Matsuyama, Tosiya Sato, 2003, Epidemiology.

A Modification of the 50 %-Conditional Power Approach for Increasing the Sample Size Based on an Interim Estimate of Treatment Difference

Y. Ohashi, Y. Matsuyama, K. Uemura, 2008 .

A comparison of the results of intent‐to‐treat, per‐protocol, and g‐estimation in the presence of non‐random treatment changes in a time‐to‐event non‐inferiority trial

Y. Matsuyama, 2010, Statistics in medicine.

Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.

Y. Matsuyama, S. Kawazu, Hiroyuki Yanagisawa, 2014, Journal of diabetes and its complications.

A Bayesian Stopping Rule for Sequential Monitoring of Serious Adverse Events

Y. Ohashi, Y. Matsuyama, K. Kashiwabara, 2014, Therapeutic innovation & regulatory science.

Dynamic prediction of repeated events data based on landmarking model: application to colorectal liver metastases data

Y. Matsuyama, Isao Yokota, 2019, BMC Medical Research Methodology.

Validation of surrogate endpoints in cancer clinical trials via principal stratification with an application to a prostate cancer trial

Y. Ohashi, Y. Matsuyama, Shiro Tanaka, 2017, Statistics in medicine.

Estimating the Effects of Time-Varying Treatments: Incidence of Fractures Among Postmenopausal Japanese Women

Y. Ohashi, Y. Matsuyama, Shiro Tanaka, 2007, Epidemiology.

Correcting for non‐compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach

Y. Matsuyama, 2002, Statistics in medicine.

Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study)

Y. Ohashi, Y. Matsuyama, Mizuki Yoshida, 2007, Clinical trials.

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin

Y. Matsuyama, T. Shinozaki, T. Kawahara, 2020, BMC Medical Research Methodology.

Estimation and comparison of rates of change in repeated-measures studies with planned dropout.

Y. Ohashi, Y. Matsuyama, I. Toyoda, 2001, Controlled clinical trials.

Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.

Y. Matsuyama, K. Oba, Takeshi Kimura, 2020, The American journal of gastroenterology.

Albumin and Hemoglobin Trajectories and Incident Disabling Dementia in Community-Dwelling Older Japanese

Y. Fujiwara, Y. Matsuyama, S. Seino, 2019, Dementia and Geriatric Cognitive Disorders.

Gait Performance Trajectories and Incident Disabling Dementia Among Community-Dwelling Older Japanese.

Y. Fujiwara, Y. Matsuyama, S. Seino, 2017, Journal of the American Medical Directors Association.

Mini‐Mental State Examination score trajectories and incident disabling dementia among community‐dwelling older Japanese adults

Y. Fujiwara, Y. Matsuyama, S. Seino, 2017, Geriatrics & gerontology international.

Prospective Study of Trajectories of Physical Performance and Mortality Among Community-Dwelling Older Japanese.

Y. Fujiwara, Y. Matsuyama, S. Seino, 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

Brief Report: Doubly Robust Estimation of Standardized Risk Difference and Ratio in the Exposed Population

Y. Matsuyama, T. Shinozaki, 2015, Epidemiology.

Trajectories of arterial stiffness and all‐cause mortality among community‐dwelling older Japanese

Y. Fujiwara, Y. Matsuyama, S. Seino, 2018, Geriatrics & gerontology international.

Sodium‐glucose cotransporter‐2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database

H. Yasunaga, H. Miyata, Y. Matsuyama, 2021, Diabetes, obesity & metabolism.

Associations between visceral obesity and renal impairment in health checkup participants: a retrospective cohort study

Y. Matsuyama, I. Masuda, K. Oba, 2020, Clinical and Experimental Nephrology.

Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan

Tetsuhiro Tanaka, M. Nangaku, Y. Matsuyama, 2020, BMJ Open Diabetes Research & Care.

Interim analysis based on the weighted log-rank test for delayed treatment effects under staggered patient entry

Y. Matsuyama, Mizuki Yoshida, 2016, Journal of biopharmaceutical statistics.

Association of Trajectories of Higher-Level Functional Capacity with Mortality and Medical and Long-Term Care Costs Among Community-Dwelling Older Japanese

Y. Fujiwara, Y. Matsuyama, S. Seino, 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.

The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.

Y. Matsuyama, S. Kawazu, Hiroyuki Yanagisawa, 2011, Diabetes research and clinical practice.

The Number of Events per Confounder for Valid Estimation of Risk Difference Using Modified Least-Squares Regression

Y. Matsuyama, Y. Hagiwara, Musashi Fukuda, 2018, American journal of epidemiology.

Comparison of sirolimus- and paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trial.

T. Kawase, H. Tamekiyo, M. Otsuka, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin

Y. Matsuyama, T. Shinozaki, T. Kawahara, 2020, BMC Medical Research Methodology.

Efficiency of ultrasensitive prostate-specific antigen assay in diagnosing biochemical failure after radical prostatectomy.

Y. Ohashi, Y. Matsuyama, Shiro Tanaka, 2007, Japanese journal of clinical oncology.

A New Association Analysis Method for Gut Microbial Compositional Data Using Ensemble Learning

Y. Matsuyama, S. Nakaji, T. Okui, 2019, Japanese Journal of Biometrics.

Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two‐stage stochastic dynamic treatment regime approach

H. Mukai, Y. Matsuyama, T. Shinozaki, 2020, Biometrics.

Associations of aging trajectories for an index of frailty score with mortality and medical and long‐term care costs among older Japanese undergoing health checkups

Y. Fujiwara, Y. Matsuyama, Takumi Abe, 2020, Geriatrics & gerontology international.

Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT)

H. Fujita, Y. Matsuyama, S. Suwa, 2015, Cardiovascular Intervention and Therapeutics.

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease

H. Naruse, Y. Matsuyama, M. Matsuzaki, 2021, Journal of atherosclerosis and thrombosis.

Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan.

M. Kudo, N. Izumi, Y. Matsuyama, 2020, Surgery.

Epidemiologic Features of HIV Infection and AIDS in Japan Estimated by the Delphi Method

Y. Matsuyama, S. Oka, S. Hashimoto, 2000 .

Monte Carlo Sensitivity Analysis for Adjusting Multiple-bias in the Longitudinal Cardiovascular Study

Y. Ohashi, Y. Matsuyama, H. Ueshima, 2010 .

Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.

P. Fitzgerald, P. Yock, Y. Matsuyama, 2017, Atherosclerosis.

Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trial.

H. Fujita, Y. Matsuyama, S. Suwa, 2016, International journal of cardiology.

Inadequacy of Prostate-Specific Antigen Doubling Time Estimates Calculated Using an Ultrasensitive Assay of Prostate-Specific Antigen for Biochemical Failure after Radical Prostatectomy

Y. Ohashi, Y. Matsuyama, T. Tominaga, 2007, Urologia Internationalis.

Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.

Y. Matsuyama, Y. Furutani, A. Takeda, 2021, Circulation.

Re: Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.

Y. Matsuyama, T. Shinozaki, Y. Hagiwara, 2017, Epidemiology.

Overlap coefficient for assessing the similarity of pharmacokinetic data between ethnically different populations

Yasuo Ohashi, Takuhiro Yamaguchi, Yutaka Matsuyama, 2005, Clinical Trials.

Attempt at Long-term Prediction of the Numbers of HIV-infected Persons and AIDS Cases in Japan Using System Analysis

Y. Matsuyama, Takuhiro Yamaguchi, S. Hashimoto, 2002 .

A simulation study for a linear measurement error model when error variances vary between measurements

Y. Matsuyama, Tosiya Sato, Y. Chiba, 2005 .

Bayesian adaptive randomization design incorporating propensity score‐matched historical controls

Y. Matsuyama, Koji Oba, Ryo Sawamoto, 2022, Pharmaceutical statistics.

Non-parametric approach for frequentist multiple imputation in survival analysis with missing covariates

Yasuhiro Hagiwara, Mitsunori Ogawa, Yoshinori Takeuchi, 2021, Statistical methods in medical research.

Sensitivity Analysis of Publication Bias in Meta-analysis : A Bayesian Approach

Yasuo Ohashi, Yutaka Matsuyama, Kimihiko Sakamoto, 2006 .

Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men.

Y. Matsuyama, M. Taguri, K. Sase, 2010, The journal of sexual medicine.

Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population.

Y. Ohashi, Y. Matsuyama, A. Takeuchi, 2013, American journal of infection control.

When to conduct probabilistic linkage vs. deterministic linkage? A simulation study

Yasuo Ohashi, Soko Setoguchi, Ying Zhu, 2015, J. Biomed. Informatics.

TCT-243 Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT Trial

Y. Matsuyama, S. Suwa, Masato Nakamura, 2014 .

A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques

Y. Matsuyama, F. Ono, Takeshi Ishikawa, 2019, Nature Biomedical Engineering.

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.

Y. Ohashi, Y. Matsuyama, S. Takashima, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Analysis of the duration and extent of the legacy effect in patients with type 2 diabetes: A real-world longitudinal study.

Y. Matsuyama, M. Suka, Hiroyuki Yanagisawa, 2019, Journal of diabetes and its complications.

Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes.

Y. Matsuyama, Y. Iwamoto, M. Suka, 2017, Diabetes research and clinical practice.

The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes

Y. Matsuyama, Y. Iwamoto, M. Suka, 2015, BMJ Open Diabetes Research and Care.

Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.

Y. Matsuyama, S. Kawazu, M. Suka, 2015, Journal of diabetes and its complications.

Time-to-effect relationships between systolic blood pressure and the risks of nephropathy and retinopathy in patients with type 2 diabetes.

Y. Matsuyama, S. Kawazu, M. Suka, 2014, Journal of diabetes and its complications.

Association between HbA1c variability and mortality in patients with type 2 diabetes.

Hiroyuki Yanagisawa, Yutaka Matsuyama, Y. Matsuyama, 2014, Journal of diabetes and its complications.

Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study

Y. Matsuyama, M. Momoeda, K. Ikuta, 2018, International Journal of Hematology.

Two-by-two cross-over study to evaluate agreement between versions of a quantitative coronary analysis system (QAngio XA)

Y. Matsuyama, K. Kozuma, K. Oba, 2017, The International Journal of Cardiovascular Imaging.

Doubly robust estimation of the generalized impact fraction.

Y. Ohashi, Y. Matsuyama, H. Ueshima, 2012, Biostatistics.

Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents.

H. Fujita, Y. Matsuyama, S. Suwa, 2016, The American journal of cardiology.

Evaluation of the DSM‐IV and ICD‐10 criteria for depressive disorders in a community population in Japan using item response theory

Y. Ono, N. Kawakami, Y. Matsuyama, 2010, International journal of methods in psychiatric research.

Association of weight gain since age 20 with non‐alcoholic fatty liver disease in normal weight individuals

T. Fukui, Y. Matsuyama, G. Deshpande, 2015, Journal of gastroenterology and hepatology.

Estimating Treatment Effect of High Hemoglobin Using the Principal Stratification Approach

Y. Matsuyama, J. Moriya, 2016 .

On hazard ratio estimators by proportional hazards models in matched-pair cohort studies

Tomohiro Shinozaki, Mohammad Ali Mansournia, Yutaka Matsuyama, 2017, Emerging Themes in Epidemiology.

Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods

Takuhiro Yamaguchi, Yutaka Matsuyama, Y. Matsuyama, 2008, Pharmaceutical statistics.

Future Prediction of the Number of HIV-infected Persons and AIDS Cases

Y. Matsuyama, S. Hashimoto, Yosikazu Nakamura, 2000 .

Delays and continuation of hospital visits among HIV-infected persons and AIDS cases in Japan.

Y. Matsuyama, S. Hashimoto, M. Kihara, 2000, Journal of epidemiology.

Trends in HIV and AIDS based on HIV/AIDS surveillance data in Japan.

Y. Matsuyama, S. Hashimoto, M. Kihara, 1999, International journal of epidemiology.

Epidemiological Characteristics of HIV and AIDS in Japan based on HIV/AIDS Surveillance Data

Y. Matsuyama, Takuhiro Yamaguchi, M. Kawado, 2004 .

Epidemiologic: Epidemiological Characteristics of HIV and AIDS in Japan based on HIV/AIDS Surveillance Data: An International Comparison

Y. Matsuyama, Takuhiro Yamaguchi, S. Hashimoto, 2004 .

The Number of Patients with HIV/AIDS Treated in Area Hospitals Specializing in AIDS Treatment in Japan

Y. Matsuyama, Takuhiro Yamaguchi, M. Kawado, 2002 .

Trends in the Number of Death Cases Reported to the HIV/AIDS Surveillance

Y. Matsuyama, S. Hashimoto, Yosikazu Nakamura, 2000 .

Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect.

Junichi Sakamoto, Satoshi Teramukai, Yutaka Matsuyama, 2004, Japanese journal of clinical oncology.

Utility of Adaptive Sample Size Designs and A Review Example

Yuki Ando, Yutaka Matsuyama, Kohei Uemura, 2017 .

Prospective Study of Arterial Stiffness and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese

Y. Fujiwara, Y. Matsuyama, S. Seino, 2015, Journal of epidemiology.

Effective prevention of cardiovascular disease and diabetes‐related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: Adjusting for treatment changes using a marginal structural proportional hazards model and a rank‐preserving structural failure time model

Y. Ohashi, Y. Matsuyama, T. Sakurai, 2012, Geriatrics & gerontology international.

Automatic Detection of Left Ventricular Dilatation and Hypertrophy from Electrocardiograms Using Deep Learning.

T. Kokubo, Y. Matsuyama, K. Fujiu, 2022, International heart journal.

The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up.

Y. Matsuyama, S. Kawazu, Toshiko Takao, 2010, Diabetes research and clinical practice.

Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study

Kengo Ito, M. Senda, K. Ishii, 2018, Alzheimer's & dementia.

Estimation of the average causal effect among subgroups defined by post-treatment variables

Y. Matsuyama, S. Morita, 2006, Clinical trials.

Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation: development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Ja

Y. Matsuyama, K. Kozuma, K. Oba, 2020, Cardiovascular Intervention and Therapeutics.

Analysis of Quality of Life Data with Death and Drop-out in Advanced Non-Small-Cell Lung Cancer Patients

Y. Ohashi, Y. Matsuyama, Kazutaka Doi, 2006 .

A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies

Y. Matsuyama, T. Shinozaki, Yoshinori Takeuchi, 2018, BMC Medical Research Methodology.

Sensitivity analysis for the estimation of rates of change with non‐ignorable drop‐out: an application to a randomized clinical trial of the vitamin D3

Y. Matsuyama, 2003, Statistics in medicine.

The effect of aging on functional decline among older Japanese living in a community: a 5-year longitudinal data analysis

Y. Matsuyama, Y. Imanaka, T. Ishizaki, 2004, Aging clinical and experimental research.

Association of trajectories of cognitive function with cause‐specific mortality and medical and long‐term care costs

Y. Fujiwara, Y. Matsuyama, Takumi Abe, 2019, Geriatrics & gerontology international.

Panel of novel urine biomarkers for incident microalbuminuria in people with type 2 diabetes mellitus

Y. Matsuyama, T. Shinozaki, T. Babazono, 2020, Diabetic medicine : a journal of the British Diabetic Association.

A Poisson Mixed Effects Model for Investigating the Exposure-by-Cohort Interaction: A Gibbs Sampling Approach

Y. Ohashi, Y. Matsuyama, H. Ueshima, 2008 .

Vesnarinone – induced WBC disorders in Japan

Y. Matsuyama, F. Takaku, Y. Ohashi, 1996, Pharmacoepidemiology and drug safety.

What is confounding, and how to adjust it?: Standardization and Marginal Structural Models

Y. Matsuyama, Tosiya Sato, 2011 .

Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L

N. Taira, Y. Matsuyama, T. Fukuda, 2023, Health and Quality of Life Outcomes.

Longitudinal effects of a nationwide lifestyle intervention program on cardiometabolic outcomes in Japan: An observational cohort study.

Y. Matsuyama, K. Kashiwabara, Yoshinori Takeuchi, 2020, Preventive medicine.

Analyzing intent-to-treat and per-protocol effects on safety outcomes using a medical information database: an application to the risk assessment of antibiotic-induced liver injury

Y. Matsuyama, T. Shinozaki, H. Kumamaru, 2018, Expert opinion on drug safety.

Estimation of controlled direct effects in time‐varying treatments using structural nested mean models: application to a primary prevention trial for coronary events with pravastatin

Y. Ohashi, Y. Matsuyama, T. Shinozaki, 2014, Statistics in medicine.

A Hierarchical Regression Model for Dietary Data Adjusting for Covariates Measurement Error by Regression Calibration: An Application to a Large Prospective Study for Diabetic Complications

Yasuo Ohashi, Masataka Taguri, Nobuhiro Yamada, 2010 .

A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques

Y. Matsuyama, F. Ono, Takeshi Ishikawa, 2019, Nature Biomedical Engineering.

A comparison of error detection rates between the reading aloud method and the double data entry method.

Yasuo Ohashi, Yutaka Matsuyama, Takuhiro Yamaguchi, 2003, Controlled clinical trials.